Pages that link to "Q39115039"
Jump to navigation
Jump to search
The following pages link to SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro (Q39115039):
Displaying 45 items.
- Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs (Q27853114) (← links)
- A New Combinatorial Optimization Approach for Integrated Feature Selection Using Different Datasets: A Prostate Cancer Transcriptomic Study (Q28647934) (← links)
- Retracted: Decreased miR-204 in H. pylori-Associated Gastric Cancer Promotes Cancer Cell Proliferation and Invasion by Targeting SOX4 (Q33831182) (← links)
- Nuclear Ep-ICD expression is a predictor of poor prognosis in "low risk" prostate adenocarcinomas (Q35103343) (← links)
- High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma (Q35188596) (← links)
- SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma (Q35837268) (← links)
- Expression of Semaphorin 4A and its potential role in rheumatoid arthritis (Q35995299) (← links)
- miR-132 inhibits lung cancer cell migration and invasion by targeting SOX4. (Q36138348) (← links)
- Upregulated Expression of SOX4 Is Associated with Tumor Growth and Metastasis in Nasopharyngeal Carcinoma (Q36249545) (← links)
- SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2 (Q36349907) (← links)
- MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition (Q36546530) (← links)
- SOX4 Promotes Progression in OLP-Associated Squamous Cell Carcinoma (Q37133681) (← links)
- MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma (Q37190245) (← links)
- miR-573 is a negative regulator in the pathogenesis of rheumatoid arthritis (Q37402448) (← links)
- GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer (Q38408978) (← links)
- SOX4 is a potential prognostic factor in human cancers: a systematic review and meta-analysis (Q38562153) (← links)
- Cul4B is a novel prognostic marker in cholangiocarcinoma (Q38624814) (← links)
- SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer (Q38705113) (← links)
- SOX4 promotes melanoma cell migration and invasion though the activation of the NF-κB signaling pathway (Q38719562) (← links)
- MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4. (Q38740509) (← links)
- MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4. (Q38798471) (← links)
- Increased expression of SOX4 is associated with colorectal cancer progression (Q38803591) (← links)
- Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells (Q38870511) (← links)
- Association of SOX4 regulated by tumor suppressor miR-30a with poor prognosis in low-grade chondrosarcoma (Q38921939) (← links)
- Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer (Q39016331) (← links)
- ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells (Q39033577) (← links)
- SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis (Q40813966) (← links)
- Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish (Q41177054) (← links)
- MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma (Q41549275) (← links)
- MicroRNA-338-3p targets SOX4 and inhibits cell proliferation and invasion of renal cell carcinoma (Q47137081) (← links)
- DownRegulated SOX4 Expression Suppresses Cell Proliferation, Migration, and Induces Apoptosis in Osteosarcoma In Vitro and In Vivo (Q47642773) (← links)
- IDH1R132H Promotes Malignant Transformation of Benign Prostatic Epithelium by Dysregulating MicroRNAs: Involvement of IGF1R-AKT/STAT3 Signaling Pathway (Q49329227) (← links)
- TRPS1 Suppresses Breast Cancer Epithelial-mesenchymal Transition Program as a Negative Regulator of SUZ12. (Q51419186) (← links)
- SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients. (Q53643055) (← links)
- Oldhamianoside II inhibits prostate cancer progression via regulation of EMT and the Wnt/β-catenin signaling pathway. (Q55001642) (← links)
- MicroRNA-539 inhibits colorectal cancer progression by directly targeting SOX4. (Q55665136) (← links)
- The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers (Q58601441) (← links)
- Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis (Q59795540) (← links)
- CUL4B promotes prostate cancer progression by forming positive feedback loop with SOX4 (Q64094671) (← links)
- Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer (Q90241249) (← links)
- SOX4 is activated by C-MYC in prostate cancer (Q90325674) (← links)
- MicroRNA-132-3p regulates cell proliferation, apoptosis, migration and invasion of liver cancer by targeting Sox4 (Q91639498) (← links)
- A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis (Q91768582) (← links)
- The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression (Q93015985) (← links)
- Age-induced accumulation of methylmalonic acid promotes tumour progression (Q98568686) (← links)